Dambo Numonyo D, Jeremiah Israel, Omietimi James E, Oyeyemi Nuvie, Kasia Benedicta E, Finomo Finomo O
Department of Obstetrics and Gynaecology, Diete-Koki Memorial Hospital, Opolo, Bayelsa state, Nigeria.
Department of Obstetrics and Gynaecology, Niger Delta University, Wilberforce Island, Bayelsa state, Nigeria.
Niger Med J. 2025 Jan 10;65(6):1037-1046. doi: 10.60787/nmj.v65i6.540. eCollection 2024 Nov-Dec.
The prevalence of gestational diabetes mellitus (GDM) is dependent on the diagnostic criteria used and there is no consensus on screening methods and diagnostic criteria. The International Association for Diabetes in Pregnancy Study Group (IADPSG) recently put forward new diagnostic criteria and encourages its adoption worldwide. The aim of this study was to determine the incidence of GDM and to compare the foeto-maternal outcomes of women diagnosed with GDM in the Federal Medical Centre, Yenagoa using the WHO 1999 and IADPSG criteria.
This was a cohort study of 340 women who were booked for antenatal care at the Federal Medical Centre, Yenagoa. Women who gave consent to participate in this study took part in a 75-gram, 2-hour oral glucose tolerance test (OGTT). The diagnosis of GDM was sought in each participant using both the WHO 1999 and the IADPSG criteria. The incidence and the foeto-maternal outcomes in women diagnosed with GDM using different criteria were compared.
The incidence of GDM was 5.3% in the IADPSG (case) group and 3.8% in the WHO (control) group. This difference was not statistically significant (p = 0.18). There was no significant difference between the groups for foetal and maternal outcomes that were assessed. Maternal outcomes were pre-eclampsia (p = 0.48), polyhydramnios (p = 0.31), insulin therapy (p = 0.35), caesarean section (p = 0.28), genital tract laceration (p = 0.18) and instrumental vaginal delivery (p = 0.34). Foetal outcomes were birth weight ≥ 4kg (p = 0.07), neonatal jaundice (p = 0.38), hypoglycaemia (p = 0.46), birth injuries (p = 0.42) and shoulder dystocia (p = 0.23).
The application of the IADPSG criteria in our environment may lead to an increase in the number of women being managed for GDM without any appreciable improvement in foetal and maternal outcomes.
妊娠期糖尿病(GDM)的患病率取决于所采用的诊断标准,并且在筛查方法和诊断标准上尚未达成共识。国际妊娠糖尿病研究组(IADPSG)最近提出了新的诊断标准,并鼓励在全球范围内采用。本研究的目的是确定GDM的发病率,并比较在耶那戈阿联邦医疗中心使用世界卫生组织(WHO)1999年标准和IADPSG标准诊断为GDM的女性的母婴结局。
这是一项对340名在耶那戈阿联邦医疗中心预约产前护理的女性进行的队列研究。同意参与本研究的女性参加了75克、2小时口服葡萄糖耐量试验(OGTT)。使用WHO 1999年标准和IADPSG标准对每位参与者进行GDM诊断。比较了使用不同标准诊断为GDM的女性的发病率和母婴结局。
IADPSG(病例)组中GDM的发病率为5.3%,WHO(对照)组为3.8%。这种差异无统计学意义(p = 0.18)。在评估的母婴结局方面,两组之间没有显著差异。母亲结局包括子痫前期(p = 0.48)、羊水过多(p = 0.31)、胰岛素治疗(p = 0.35)、剖宫产(p = 0.28)、生殖道裂伤(p = 0.18)和器械助产阴道分娩(p = 0.34);胎儿结局包括出生体重≥4kg(p = 0.07)、新生儿黄疸(p = 0.38)、低血糖(p = 0.46)、产伤(p = 0.42)和肩难产(p = 0.23)。
在我们的环境中应用IADPSG标准可能会导致接受GDM管理的女性数量增加,但母婴结局并无明显改善。